Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Use of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists.

Naylor J, Suckow AT, Seth A, Baker DJ, Sermadiras I, Ravn P, Howes R, Li J, Snaith MR, Coghlan MP, Hornigold DC.

Biochem J. 2016 Sep 15;473(18):2881-91. doi: 10.1042/BCJ20160476. Epub 2016 Jul 15.

PMID:
27422784
2.

Recombinant expression and in vitro characterisation of active Huwentoxin-IV.

Sermadiras I, Revell J, Linley JE, Sandercock A, Ravn P.

PLoS One. 2013 Dec 6;8(12):e83202. doi: 10.1371/journal.pone.0083202. eCollection 2013.

3.

Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity.

Kwok HF, Buick RJ, Kuehn D, Gormley JA, Doherty D, Jaquin TJ, McClurg A, Ward C, Byrne T, Jaworski J, Leung KL, Snoddy P, McAnally C, Burden RE, Gray B, Lowry J, Sermadiras I, Gruszka N, Courtenay-Luck N, Kissenpfennig A, Scott CJ, Johnston JA, Olwill SA.

Mol Cancer. 2011 Dec 14;10:147. doi: 10.1186/1476-4598-10-147.

Supplemental Content

Loading ...
Support Center